Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder
Phase 4 Study of Escitalopram Treatment and Biomarkers in Major Depressive Disorder
To explore electrophysiologic parameters and biomarkers predicting treatment response of patients with major depressive disorder To explore electrophysiologic parameters and biomarkers predicting suicide risk of patients with major depressive disorder
Case-control study Repeated measures design
Inclusion Criteria:
Exclusion Criteria:
cjs0107@gmail.com82-31-787-7437